DE60014932D1 - Diazocindionderivate und ihre verwendung als tryptase inhibitoren - Google Patents

Diazocindionderivate und ihre verwendung als tryptase inhibitoren

Info

Publication number
DE60014932D1
DE60014932D1 DE2000614932 DE60014932T DE60014932D1 DE 60014932 D1 DE60014932 D1 DE 60014932D1 DE 2000614932 DE2000614932 DE 2000614932 DE 60014932 T DE60014932 T DE 60014932T DE 60014932 D1 DE60014932 D1 DE 60014932D1
Authority
DE
Germany
Prior art keywords
diazocindion
derivatives
tryptase inhibitors
inhibitors
tryptase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2000614932
Other languages
English (en)
Other versions
DE60014932T2 (de
Inventor
Thomas Baer
Thomas Martin
Josef Stadlwieser
Andreas Dominik
Daniela Bundschuh
Karl Zech
Christian Sommerhoff
Wolf-Ruediger Ulrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE60014932D1 publication Critical patent/DE60014932D1/de
Application granted granted Critical
Publication of DE60014932T2 publication Critical patent/DE60014932T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
DE60014932T 1999-08-10 2000-08-09 Diazocindionderivate und ihre verwendung als tryptase inhibitoren Expired - Fee Related DE60014932T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99115737 1999-08-10
EP99115737 1999-08-10
PCT/EP2000/007720 WO2001010848A2 (en) 1999-08-10 2000-08-09 Diazocin-dione derivatives and their use s tryptase inhibitors

Publications (2)

Publication Number Publication Date
DE60014932D1 true DE60014932D1 (de) 2004-11-18
DE60014932T2 DE60014932T2 (de) 2005-10-13

Family

ID=8238754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014932T Expired - Fee Related DE60014932T2 (de) 1999-08-10 2000-08-09 Diazocindionderivate und ihre verwendung als tryptase inhibitoren

Country Status (19)

Country Link
US (1) US6673786B1 (de)
EP (1) EP1208089B1 (de)
JP (1) JP2003506442A (de)
KR (1) KR20020016942A (de)
CN (1) CN1378538A (de)
AT (1) ATE279398T1 (de)
AU (1) AU777026B2 (de)
BR (1) BR0013090A (de)
CA (1) CA2381919A1 (de)
DE (1) DE60014932T2 (de)
DK (1) DK1208089T3 (de)
ES (1) ES2230155T3 (de)
IL (1) IL147649A0 (de)
MX (1) MXPA02001426A (de)
PL (1) PL356170A1 (de)
PT (1) PT1208089E (de)
SI (1) SI1208089T1 (de)
WO (1) WO2001010848A2 (de)
ZA (1) ZA200201112B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200402322T4 (tr) 1999-12-20 2004-12-21 Altana Pharma Ag Triptaz inhibitörler
US6815557B2 (en) 1999-12-20 2004-11-09 Altana Pharma Ag Tryptase inhibitors
EP1358182B1 (de) 2001-01-31 2004-08-11 ALTANA Pharma AG Diazocinderivate und deren verwendung als tryptase inhibitoren
AU2002253035B8 (en) 2001-02-21 2008-02-21 Altana Pharma Ag Tryptase inhibitors
ATE364037T1 (de) 2001-02-21 2007-06-15 Altana Pharma Ag Tryptasehemmer
AU2002314165B2 (en) 2001-06-19 2008-02-21 Altana Pharma Ag Tryptase inhibitors
WO2006044133A1 (en) * 2004-09-24 2006-04-27 Axys Pharmaceuticals, Inc. Active ketone inhibitors of tryptase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200561A1 (en) 1994-09-23 1996-03-28 Ken D. Rice Compositions and methods for treating mast-cell inflammatory conditions
AU733621B2 (en) 1996-07-30 2001-05-17 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating diseases associated with tryptase activity
EP1060175B1 (de) 1998-02-06 2004-11-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tryptase-inhibitoren

Also Published As

Publication number Publication date
MXPA02001426A (es) 2002-08-12
ES2230155T3 (es) 2005-05-01
WO2001010848A3 (en) 2001-12-06
JP2003506442A (ja) 2003-02-18
AU7273700A (en) 2001-03-05
WO2001010848A2 (en) 2001-02-15
IL147649A0 (en) 2002-08-14
CN1378538A (zh) 2002-11-06
EP1208089B1 (de) 2004-10-13
DK1208089T3 (da) 2005-02-14
BR0013090A (pt) 2002-04-30
ATE279398T1 (de) 2004-10-15
EP1208089A2 (de) 2002-05-29
PT1208089E (pt) 2005-02-28
AU777026B2 (en) 2004-09-30
KR20020016942A (ko) 2002-03-06
US6673786B1 (en) 2004-01-06
SI1208089T1 (en) 2005-04-30
ZA200201112B (en) 2002-11-27
CA2381919A1 (en) 2001-02-15
DE60014932T2 (de) 2005-10-13
PL356170A1 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
DE60317093D1 (de) Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide
GB0130341D0 (en) Compounds
ATE241621T1 (de) Arylsulfonyle als faktor xa inhibitoren
WO2005040116A3 (en) Indolinone derivatives and their use in treating disease-states such as cancer
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
DE60234164D1 (de) Neues a-liponsäurederivat und dessen verwendung
DE60321958D1 (de) Indazolderivate und ihre verwendung als crf antagonisten
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE282605T1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
ATE279398T1 (de) Diazocindionderivate und ihre verwendung als tryptase inhibitoren
ATE353884T1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
DE60221570D1 (de) Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen-inhibitoren
DE50004731D1 (de) Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
DE60316134D1 (de) Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva
ATE411301T1 (de) Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
DE60311000D1 (de) Indolderivate und deren verwendung als 5-ht liganden
DE60200935D1 (de) Diazocinderivate und deren verwendung als tryptase inhibitoren
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase
DE50001742D1 (de) Arylsulfonamid-substituierte benzimidazolderivate und ihre verwendung als tryptase-inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE

8339 Ceased/non-payment of the annual fee